Persistent hyperactivation of the ERK1/2 cascade is a hallmark of various cancers, where its constitutive activation drives tumorigenesis by promoting uncontrolled proliferation, enhanced survival, increased migratory and invasive capacity, and extensive remodeling of the ECM. The gene discussed is MAPK3; the disease is cancer.